Because excessive secretion of gastric juice is a common concomitant of chronic peptic ulcers, various workers have looked for substances having an inhibitory action. The secretion of HCl, though partly controlled by the vagus nerves, is peculiar in being stimulated by histamine and in being not greatly affected by atropine. The effect of atropine is described differently by different observers (Polland, 1930; Atkinson and Ivy, 1937; Gray, 1937; King, Comfort, and Osterberg, 1944 ). It appears to be more effective in abolishing the secretion produced by giving a meal than that produced by injecting histamine. Davenport (1940) 
Because excessive secretion of gastric juice is a common concomitant of chronic peptic ulcers, various workers have looked for substances having an inhibitory action. The secretion of HCl, though partly controlled by the vagus nerves, is peculiar in being stimulated by histamine and in being not greatly affected by atropine. The effect of atropine is described differently by different observers (Polland, 1930; Atkinson and Ivy, 1937; Gray, 1937; King, Comfort, and Osterberg, 1944 ). It appears to be more effective in abolishing the secretion produced by giving a meal than that produced by injecting histamine. Davenport (1940) , and later Rehm and Enelow (1945) , investigated the effect of sodium thiocyanate; when given intravenously to dogs in sufficient amount, it was found to inhibit the secretion of HC1 completely.
Recently Babkin and Karp (1947) have observed that the two antimalarial substances quinine and mepacrine (atebrin), when injected intravenously into dogs, depressed the secretion of gastric juice produced by stimulation of the vagus nerves. The doses they used were large in relation to the doses ordinarily given to man; thus a dog of 10 kg. received 0.2 g. quinine bisulphate or 75 mg. mepacrine. When secretion was produced by the injection of histamine, neither quinine nor mepacrine affected it.
Recently a simple method of examining substances for an inhibitory action on gastric secretion has been developed in this laboratory by Wood (1948) ; cats are used, anaesthetized by cyclopropane or pentobarbitone (nembutal). The only essential point in which the method differs from that proposed by Lim (1923) , and modified by Roth and Ivy (1944) When larger amounts of paludrine were given by slow infusion instead of by single injection, the periods of reduced gastric secretion lasted until the termination of the experiment. Fig. 2 shows the mean effect of infusing 60 mg. paludrine during 30 min. into 6 cats. The graph records the change in the total free acid excreted. The volume of juice per 10 min. was measured; 1 ml. of this juice was then titrated against N/50 NaOH using thymol blue as the indicator. The total secretion of free acid per 10 min. was then calculated. The initial rise in secretion shown in Fig. 2 occurred in two of the six experiments for 20 min.; thereafter there was a prolonged fall. In these experiments, both the volume of juice secreted and the concentration of free acid in the juice were reduced. The only effect the paludrine infusion had on the blood pressure was to cause an occasional initial rise. In four other experiments, doses of paludrine from 120 mg. to 180 mg. were infused. Table I shows these results. It can be seen that there was an initial stimulation of the secretion in Exp. 1. In these experiments, as in those recorded in Fig. 2 , the volume of juice secreted did not recover from its low value. In all experiments the rate of histamine infusion the total secretion of the hour previous to the was usually 15 fig. per min., or more, throughout. administration. Only in two experiments was it 10 jutg. per min.
In an effort to obtain a more quantitative estiThis is a high rate of histamine infusion, providing mation of the inhibitory power, the principle of a powerful stimulus to secretion and a severe test the method recently described by Howat and for an inhibitory substance.
Schofield (1948) was adopted. The main differPaludrine consists of the biguanide molecule, ence between this method and that previously substituted at one end with the p-chlorophenyl used was that, instead of giving the test substance radical, and at the other with the isopropyl radical. during a constant infusion of histamine, it was Compounds structurally related to paludrine were given bqtween two periods of histamine infusion, also tested to see if they would inhibit gastric each of 48 min. duration. The second response secretion. The first three compounds tested were was expressed as a percentage of the first, the biguanide, isopropyl biguanide, and di-isopropyl biguanide. All were found to be inactive as shown by the results in Table LI . These results were Tables II and  III have been combined and arranged in order of  activity, to give Table IV. DISCUSSION AND SUMMARY Extensive trials of paludrine in men have been made in testing its value against malaria, and it is known to be a well-tolerated substance. A large dose produces gastrointestinal symptoms in some individuals, and Hughes, Schmidt, and Smith (1947) have described how dogs fed on a diet containing paludrine become disinclined to eat. It seems probable that these observations are related to our finding that paludrine exerts an inhibitory action on the volume and acidity of gastric juice evoked by histamine. A similar compound in which the isopropyl group of paludrine was replaced by a methyl group was found to exert a similar effect. Other related substances had less or no effect. We have observed an initial stimulating action in a few experiments. precedine the inhibition. This is probably an example of a preliminary stimulant action preceding inhibition, which is commonly met in inhibitory drugs. Thus the first effect of taking atropine by mouth is to slow the pulse rate and cause the hands to become moist in most people ; the later effect is of course the opposite. Atropine appears first to stimulate and later to paralyse the cholinergic nerve endings in the heart and sweat glands.
We are greatly indebted to Dr. F. L. Rose, of Imperial Chemical (Pharmaceuticals) Limited, for the substances which we have examined. The work was done while one of us (J. R. V.) was in receipt of a grant from the Therapeutic Research Corporation.
